By Tricitynews Reporter
Chandigarh
17th July:- A Three Day Mega scientific meet on
Oncology–‘Best of ASCO’ (American Society of Clinical Oncology) organised by
ASCO in collaboration with Max Hospital, Mohali, has concluded.
Dr Gautam Goyal, Organising Secretary
& Medical Oncologist, Max Hospital said that the objective of ‘Best of
ASCO’ 2017 was to share most recent research data & papers which have had
an impact on patient care, and were presented in the Global ASCO Conference
held in June at Chicago, USA. Over 3 days, as many as 500 Cancer Specialists,
Surgeons & Radiation Oncologists from abroad & pan India discussed
path-breaking papers in Cancer.
Dr. Sachin Gupta, Co-Organising
Secretary & Medical Oncologist, Max Hospital said that with the theme of
‘Demystifying Advances in Oncology’, the Conference gave a great opportunity to
the fraternity to know about latest paradigms in cancer treatment. "What
came up at the conference was that immuno-oncology therapies do hold hope in
cancer treatment. Precision or molecular oncology too heralds lot of promise.
The Conference discussed threadbare
these newer treatment protocols of Immuno & Molecular oncology.
Dr. Bar Jair, Dy Director, Institute
of Oncology, Sheeba Medical Centre, Israel; Dr. Jacob Sands, Assistant
Professor, Lahey Medical centre, Boston, Dr. Amit Oza & Dr. Sanjeev
Agarwala were the Oncologists from abroad who gave talks. A few well-known
names from India who gave presentations were Dr.Purvish Parikh,Director
Precision Medicine, Asian Institute of Oncology, Mumbai; Prof. Kumar
Prabhash, Tata Memorial Hospital, Mumbai & Dr. D C Dovol, Rajeev
Gandhi Cancer Institute, Delhi among others. Dr Harit Chaturvedi, Chairman
(Cancer Care), Max Healthcare also attended the meet.
Dedicated lectures by top Oncologists
engaged the Gynaecologists’ fraternity on aspects like facts of cancer, the
diagnosis, approach to treatment & newer modalities of treatment. There
was an exclusive lecture on HIPEC a new form of treatment of ovarian cancer.
Organ Preservation surgery in cancer was also an interesting point of
discussion.
No comments:
Post a Comment